Form 4: Pure Bioscience VP of Finance Acquires Stock Options
SEC Form 4 Filing
Mark Stuart Elliott, Vice President of Finance at Pure Bioscience, acquired stock options for 155,000 shares at an exercise price of $0.07 on August 20, 2024.
Summary
- On August 20, 2024, Mark Stuart Elliott, the Vice President of Finance at Pure Bioscience, acquired stock options for 155,000 shares.
- The exercise price for these options is $0.07 per share.
- The options vest in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025.
- The options expire on August 20, 2034.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock option grants to a company executive.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership of securities by a company insider. It's a routine part of corporate governance and transparency.
Stakeholder Impact
- The granting of stock options aligns the executive's interests with those of the shareholders, potentially incentivizing performance that benefits the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Date of earliest transaction: Grant of stock options for 155,000 shares at $0.07 exercise price. |
| 08/20/2024 | First vesting date for the stock options. |
| 11/20/2024 | First vesting date for the stock options. |
| 02/20/2025 | Second vesting date for the stock options. |
| 05/20/2025 | Third vesting date for the stock options. |
| 08/20/2025 | Fourth vesting date for the stock options. |
| 08/20/2034 | Expiration date of the stock options. |
| 08/22/2024 | Date of Form 4 filing. |
Keywords
stock options, Form 4, insider trading, Mark Stuart Elliott, Pure Bioscience, PURE, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.